Healthcare Value Capital, LLC
Woodcliff Lake, NJ · CIK 1458461 · 13F filing filed 2021-08-16
No investment adviser registration (Form ADV) found for this filer. It may be a parent company whose subsidiaries are the registered advisers, a bank or insurer, or a manager based outside the US.
- Others nearbyWoodcliff Lake, NJ
$46.2m
reported value
+18.0% vs Q1 2021
18positions
73.7%in top 10
1 new
9 added
0 reduced
1 sold out
vs Q1 2021
Options: 5 call positions ($3.9m notional), 0 put positions (— notional) – listed below, not included above.
Holdings, Q2 2021
The small lines show how much was held over the last 4 quarters (adjusted for stock splits).
| Security | Value | Change |
|---|---|---|
| GILEAD SCIENCES INC GILD | $5.2m11.17% | Unchanged |
| GLAXOSMITHKLINE PLC SPONSORED ADR | $4.0m8.61% | Unchanged |
| PFIZER INC PFE | $3.9m8.47% | Unchanged |
| ALKERMES PLC ALKS | $3.7m7.95% | Added +50.0k |
| BRISTOL-MYERS SQUIBB CO BMY | $3.3m7.23% | Added +25.0k |
| MERCK & CO INC MRK | $3.1m6.73% | Added +20.0k |
| ASTRAZENECA PLC SPONSORED ADR | $3.0m6.48% | Added +25.0k |
| CLOVIS ONCOLOGY INC CLVS | $2.9m6.27% | Added +50.0k |
| IRONWOOD PHARMACEUTICALS INC IRWD | $2.6m5.57% | Unchanged |
| AMRYT PHARMA PLC SPONSORED ADS | $2.4m5.25% | Added +44.4k |
| COLLEGIUM PHARMACEUTICAL INC COLL | $2.4m5.11% | Unchanged |
| ANTARES PHARMA INC ATRS | $2.2m4.71% | Unchanged |
| TYME TECHNOLOGIES INC TYME | $1.9m4.09% | Unchanged |
| VYNE THERAPEUTICS INC COM | $1.6m3.42% | Added +50.0k |
| GREENLANE HLDGS INC CL A | $1.6m3.38% | Added +100.0k |
| MIMEDX GROUP INC MDXG | $1.6m3.38% | New |
| ADAMAS PHARMACEUTICALS INC ADMS | $528.0k1.14% | Unchanged |
| GAMIDA CELL LTD SHS | $481.0k1.04% | Added +25.0k |
Sold out since Q1 2021
| Security | Value then |
|---|---|
| AURINIA PHARMACEUTICALS INC AUPH | $1.3m100.0k shares |
Options (notional value)
| Underlying | Notional | Change |
|---|---|---|
| PROSHARES TR Call | $914.0k100.0k shares | New |
| PROSHARES TR Call | $911.0k50.0k shares | Reduced |
| AMARIN CORP PLC Call | $876.0k200.0k shares | Reduced |
| IRONWOOD PHARMACEUTICALS INC IRWD · Call | $644.0k50.0k shares | Unchanged |
| PROSHARES TR II Call | $602.0k25.0k shares | New |